AG˹ٷ

STOCK TITAN

AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Amgen (NASDAQ:AMGN) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation will take place on Wednesday, September 3, 2025, at 10:15 a.m. ET. Dr. Paul Burton, the company's Senior Vice President and Chief Medical Officer, will represent Amgen at the conference.

The presentation will be accessible via webcast on Amgen's website under the Investors section, with the recording remaining available for replay for at least 90 days following the event.

Amgen (NASDAQ:AMGN) ha annunciato la propria partecipazione alla Wells Fargo Healthcare Conference 2025. La presentazione si terrà mercoledì 3 settembre 2025 alle 10:15 ET. Il dott. Paul Burton, Senior Vice President e Chief Medical Officer dell'azienda, rappresenterà Amgen durante l'evento.

La presentazione sarà trasmessa in webcast sul sito web di Amgen nella sezione Investor, e la registrazione resterà disponibile per la visione on demand per almeno 90 giorni dopo l'evento.

Amgen (NASDAQ:AMGN) ha anunciado su participación en la Wells Fargo Healthcare Conference 2025. La presentación tendrá lugar el miércoles 3 de septiembre de 2025 a las 10:15 a.m. ET. El Dr. Paul Burton, Vicepresidente Senior y Chief Medical Officer de la compañía, representará a Amgen en la conferencia.

La presentación será accesible vía webcast en el sitio web de Amgen en la sección de Inversores, y la grabación permanecerá disponible para reproducción durante al menos 90 días después del evento.

Amgen (NASDAQ:AMGN)2025 Wells Fargo Healthcare Conference� 참가한다� 발표했습니다. 발표� 2025� 9� 3� 수요� 동부시간 오전 10� 15�� 진행됩니�. 회사� 수석부사장이자 Chief Medical Officer� Paul Burton 박사가 Amgen� 대표해 참석합니�.

발표� 투자� 섹션� Amgen 웹사이트� 통해 웹캐스트� 시청� � 있으�, 녹화본은 행사 � 최소 90� 동안 다시보기� 제공됩니�.

Amgen (NASDAQ:AMGN) a annoncé sa participation à la Wells Fargo Healthcare Conference 2025. La présentation aura lieu le mercredi 3 septembre 2025 à 10h15 (heure de l'Est). Le Dr Paul Burton, Senior Vice President et Chief Medical Officer de la société, représentera Amgen lors de la conférence.

La présentation sera diffusée en webcast sur le site web d'Amgen dans la section Investisseurs, et l'enregistrement restera disponible en replay pendant au moins 90 jours après l'événement.

Amgen (NASDAQ:AMGN) gab seine Teilnahme an der Wells Fargo Healthcare Conference 2025 bekannt. Die Präsentation findet am Mittwoch, 3. September 2025, um 10:15 Uhr ET statt. Dr. Paul Burton, Senior Vice President und Chief Medical Officer des Unternehmens, wird Amgen auf der Konferenz vertreten.

Die Präsentation wird per Webcast auf der Amgen-Website im Investorenbereich zugänglich sein; die Aufzeichnung bleibt mindestens 90 Tage nach der Veranstaltung für einen Replay verfügbar.

Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., Aug. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 Wells Fargo Healthcare Conference at 10:15 a.m. ET on Wednesday, Sept. 3, 2025. Paul Burton, M.D., Ph.D, senior vice president and chief medical officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website,, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

dzܳ

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago,Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. 

In 2024,Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow us on X (formerly known as Twitter),LinkedIn,Instagram,YouTubeԻThreads.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Adam Elinoff, 805-490-9578 (investors) 

Cision View original content to download multimedia:

SOURCE Amgen

FAQ

When is Amgen (AMGN) presenting at the 2025 Wells Fargo Healthcare Conference?

Amgen will present on Wednesday, September 3, 2025, at 10:15 a.m. ET.

Who will be presenting for Amgen at the Wells Fargo Healthcare Conference?

Dr. Paul Burton, Amgen's Senior Vice President and Chief Medical Officer, will present at the conference.

Where can I watch Amgen's Wells Fargo Healthcare Conference presentation?

The presentation will be available via webcast on Amgen's website (www.amgen.com) under the Investors section.

How long will Amgen's Wells Fargo conference presentation be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.
Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Latest SEC Filings

AMGN Stock Data

155.03B
537.17M
0.21%
84.06%
2.33%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
United States
THOUSAND OAKS